Safety Study of Replication-competent Adenovirus (Delta-24-rgd) in Patients With Recurrent Glioblastoma

Clinical trial NCT01582516 · COMPLETED

Trial details

NCT number: NCT01582516
Sponsor: Erasmus Medical Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Brain Tumor Recurring Glioblastoma

Start date: 2010-06-01
Primary completion: 2014-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.